Company Profile

NanoCellect Biomedical Inc (AKA: Nanosort LLC)
Profile last edited on: 11/7/2019      CAGE: 5TGH7      UEI: MSN6LQLSWWJ8

Business Identifier: Microfluidic flow cytometry platforms
Year Founded
2009
First Award
2010
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7770 Regents Road Unit 113390
San Diego, CA 92122
   (858) 356-5965
   N/A
   www.nanocellect.com
Location: Single
Congr. District: 50
County: San Diego

Public Profile

With the onjective to facilitate biomedical breakthroughs by making cell analysis and sorting technology more affordable and easier to use, NanoCellect Biomedical offers microfluidic flow cytometry platforms that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, and basic research. Spun out of University of Calfornia SanDeigo., the firm dedicated 6 years developing the foundation of the technology before launching the WOLF (the firm's first product) in 2016. NanoCellect Biomedical Inc. WOLF Cell Sorter was designed to provide cell sorting via a small, affordable machine avoiding the probelms of standard flow cytometers that are often shared amongst labs, leading to conflicts in sample handling and scheduling. Critically, existing cell sorters can also cause cell damaging shear stress that affects downstream applications, create biohazardous aerosols, and require highly trained technicians. The WOLF Cell Sorter uses an on-chip piezoacoustic actuator that gently directs cells into collection channels. This unique system allows analysis and sorting to take place within a disposable chip, which eliminates sample-to-sample contamination and biohazard aerosols. An embedded cell sorting verification system gives instant feedback of sorting accuracy.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
250-500
Revenue Range
20M-50M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $1,764,496
Project Title: AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
2020 2 NIH $1,716,548
Project Title: 3D Imaging Flow Cytometer
2018 2 NIH $1,796,513
Project Title: High-Throughput Single-Cell Sorting and Kinetic Analysis of Secreted Particles
2018 2 NIH $1,713,877
Project Title: Imaging Flow Cytometry Enabled by a Spatial-Frequency Filter
2016 2 NIH $2,628,863
Project Title: Lab-On-A-Chip Flow Cytometer Using Color-Space-Time (COST)) Coding Method

Key People / Management

  Jose M Morachis -- Founder ; President and CEO

  William Alaynick -- Founder, COO

  Constance Ardilla -- BioEngineer

  Sung Hwan Cho -- CTO

  Fiona Chou -- Finance and Accounting

  Nate Heintzman -- Founder

  Yuhwa Lo -- Founder

  Judy Macemon -- VP of Marketing

  Jerry (Zhe) Mei -- Senior Engineer

  Gerardo Narez -- Mechanical Engineer

  Rick Segil -- Operations